Candriam SCA’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.1M | Sell |
526,267
-201,750
| -28% | -$7.34M | 0.11% | 173 |
|
|
2025
Q1 | $26.4M | Buy |
728,017
+53,760
| +8% | +$1.95M | 0.17% | 129 |
|
|
2024
Q4 | $28.4M | Sell |
674,257
-38,835
| -5% | -$1.63M | 0.16% | 126 |
|
|
2024
Q3 | $39.6M | Buy |
713,092
+24,150
| +4% | +$1.34M | 0.23% | 100 |
|
|
2024
Q2 | $28.3M | Buy |
688,942
+171,345
| +33% | +$7.04M | 0.17% | 126 |
|
|
2024
Q1 | $24.2M | Buy |
517,597
+369,117
| +249% | +$17.2M | 0.15% | 142 |
|
|
2023
Q4 | $7.1M | Buy |
148,480
+99,000
| +200% | +$4.73M | 0.05% | 299 |
|
|
2023
Q3 | $1.76M | Hold |
49,480
| – | – | 0.01% | 466 |
|
|
2023
Q2 | $2.28M | Sell |
49,480
-11,155
| -18% | -$515K | 0.02% | 474 |
|
|
2023
Q1 | $2.24M | Buy |
60,635
+11,155
| +23% | +$412K | 0.02% | 557 |
|
|
2022
Q4 | $2.29M | Hold |
49,480
| – | – | 0.02% | 554 |
|
|
2022
Q3 | $2.05M | Hold |
49,480
| – | – | 0.01% | 579 |
|
|
2022
Q2 | $2.95M | Hold |
49,480
| – | – | 0.02% | 418 |
|
|
2022
Q1 | $3.59M | Hold |
49,480
| – | – | 0.02% | 413 |
|
|
2021
Q4 | $4.16M | Hold |
49,480
| – | – | 0.03% | 391 |
|
|
2021
Q3 | $4.46M | Hold |
49,480
| – | – | 0.03% | 420 |
|
|
2021
Q2 | $4.72M | Sell |
49,480
-48,949
| -50% | -$4.67M | 0.03% | 417 |
|
|
2021
Q1 | $13.1M | Hold |
98,429
| – | – | 0.11% | 211 |
|
|
2020
Q4 | $13.6M | Buy |
+98,429
| New | +$13.6M | 0.11% | 214 |
|
|
2020
Q2 | – | Sell |
-121,500
| Closed | -$5.07M | – | 852 |
|
|
2020
Q1 | $5.07M | Hold |
121,500
| – | – | 0.06% | 342 |
|
|
2019
Q4 | $5.19M | Sell |
121,500
-19,000
| -14% | -$811K | 0.06% | 349 |
|
|
2019
Q3 | $6.01M | Buy |
140,500
+15,000
| +12% | +$642K | 0.08% | 278 |
|
|
2019
Q2 | $7.93M | Buy |
125,500
+10,000
| +9% | +$632K | 0.1% | 228 |
|
|
2019
Q1 | $8.01M | Hold |
115,500
| – | – | 0.1% | 234 |
|
|
2018
Q4 | $5.02M | Buy |
115,500
+2,400
| +2% | +$104K | 0.08% | 282 |
|
|
2018
Q3 | $8.63M | Buy |
113,100
+28,100
| +33% | +$2.15M | 0.11% | 212 |
|
|
2018
Q2 | $6.53M | Sell |
85,000
-6,000
| -7% | -$461K | 0.1% | 250 |
|
|
2018
Q1 | $4.64M | Buy |
91,000
+17,000
| +23% | +$867K | 0.08% | 293 |
|
|
2017
Q4 | $3.43M | Buy |
74,000
+14,000
| +23% | +$649K | 0.06% | 342 |
|
|
2017
Q3 | $3.2M | Hold |
60,000
| – | – | 0.06% | 364 |
|
|
2017
Q2 | $3.73M | Sell |
60,000
-9,000
| -13% | -$559K | 0.07% | 330 |
|
|
2017
Q1 | $4.68M | Sell |
69,000
-8,000
| -10% | -$542K | 0.09% | 266 |
|
|
2016
Q4 | $5.41M | Buy |
77,000
+27,000
| +54% | +$1.9M | 0.12% | 196 |
|
|
2016
Q3 | $3.55M | Sell |
50,000
-10,000
| -17% | -$709K | 0.09% | 251 |
|
|
2016
Q2 | $2.94M | Sell |
60,000
-4,000
| -6% | -$196K | 0.08% | 254 |
|
|
2016
Q1 | $4.03M | Buy |
64,000
+33,720
| +111% | +$2.12M | 0.1% | 223 |
|
|
2015
Q4 | $3.4M | Buy |
30,280
+4,000
| +15% | +$449K | 0.09% | 235 |
|
|
2015
Q3 | $2.53M | Sell |
26,280
-9,720
| -27% | -$936K | 0.06% | 305 |
|
|
2015
Q2 | $3.69M | Sell |
36,000
-24,000
| -40% | -$2.46M | 0.08% | 279 |
|
|
2015
Q1 | $3.73M | Buy |
+60,000
| New | +$3.73M | 0.08% | 303 |
|